Search
Facial Treatments
Body Treatments
Injectables
Plastic Surgery
Your Esthetic Advisor
Beauty and Lifestyle Magazine
Facial Treatments
Body Treatments
Injectables
Plastic Surgery
Home
Tags
Interim
Tag: Interim
Injectables
Evolus to Present Phase 2 Interim Data from Jeuveau® “Extra … – Business Wire
Esthetic Advisor
-
March 9, 2023
0
Facial Treatments
“Extra-Strength” Formulation of Jeuveau® Demonstrates Effects Lasting 26 Weeks in Interim Phase II Data Results, Representing Prolonged 6-Month Performance
Esthetic Advisor
-
February 2, 2023
0
Injectables
Evolus (EOLS) Reports “Extra-Strength” Formulation of Jeuveau Demonstrates Effects Lasting 26 Weeks in Interim Phase II Data
Esthetic Advisor
-
January 30, 2023
0
Injectables
“Extra-Strength” Formulation of Jeuveau® Demonstrates Effects Lasting 26 Weeks in Interim Phase II Data Results, Representing Prolonged 6-Month Performance | News
Esthetic Advisor
-
January 28, 2023
0
Facial Treatments
“Extra-Strength” Formulation of Jeuveau® Demonstrates Effects Lasting 26 Weeks in Interim Phase II Data Results, Representing Prolonged 6-Month Performance
Esthetic Advisor
-
January 28, 2023
0
Injectables
“Extra-Strength” Formulation of Jeuveau® Demonstrates Effects Lasting 26 Weeks in Interim Phase II Data Results, Representing Prolonged 6-Month Performance
Esthetic Advisor
-
January 28, 2023
0
Injectables
Evolus to Present Phase 2 Interim Data from Jeuveau ‘Extra-Strength’ Dose for Extended Duration Study at 2023 IMCAS World Congress
Esthetic Advisor
-
January 24, 2023
0
Facial Treatments
Evolus to Present Phase 2 Interim Data from Jeuveau® “Extra-Strength” Dose for Extended Duration Study at 2023 IMCAS World Congress
Esthetic Advisor
-
January 23, 2023
0
Injectables
Evolus to Present Phase 2 Interim Data from Jeuveau® “Extra-Strength” Dose for Extended Duration Study at 2023 IMCAS World Congress
Esthetic Advisor
-
January 23, 2023
0